Press releases
Curium announces first commercial doses in the Netherlands of PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
19th March 2024
Latest news, Events and Press Releases
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
Please direct any media inquiries to Camilla Campbell, VP Communications at camilla.campbell@curiumpharma.com.
Press releases
Press releases
Curium announces first commercial doses in Italy of PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
7th March 2024
Press releases
Curium announces submission of the marketing authorization application for PYLCLARI®, an innovative (18F)-PSMA PET tracer indicated in adults with prostate cancer to Swissmedic
21st February 2024
Press releases
Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use
6th February 2024
Press releases
Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule
21st November 2023
Press releases
Curium announces first patients in Europe injected with Pylclari® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
16th November 2023
Press releases
Curium and PIUR IMAGING announce thyroid imaging partnership in Germany to enable tomographic 3D ultrasound solutions
25th October 2023
Press releases
Curium announces exclusive distribution agreement in Switzerland with b.e. Imaging for PYLCLARI™, an innovative 18F-PSMA PET tracer indicated in adults with prostate cancer
7th September 2023
Press releases
Curium announces achievement of co-primary endpoints in phase 2 of its phase 1/2 SOLAR clinical trial imaging men with histologically-proven prostate cancer using copper Cu 64 PSMA I&T
15th August 2023
Press releases
Curium receives marketing authorization in the EU for Pylclari™, an innovative 18F-PSMA PET tracer indicated in adults with prostate cancer
28th July 2023
Press releases
Curium announces license and development agreement with Lantheus for AI-based PSMA PET software in Europe
25th July 2023
Press releases
Curium announces publication of [18F]DCFPyL versus [18F]fuoromethylcholine results from European phase III Study (PYTHON trial)
21st July 2023